The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
BDNF Gene-Modified Mesenchymal Stem Cells Promote Functional Recovery and Reduce Infarct Size in the Rat Middle Cerebral Artery Occlusion Model
Open accessAbstract
Examination of the clinical therapeutic efficacy of using bone marrow stromal cells, including mesenchymal stem cells (MSC), has recently been the focus of much investigation. MSC were reported to ameliorate functional deficits after stroke in rats, with some of this improvement possibly resulting from the action of cytokines secreted by these cells. To enhance such cytokine effects, we transfected telomerized human MSC with the BDNF gene using a fiber-mutant F/RGD adenovirus vector and investigated whether these cells contributed to improved functional recovery in a rat transient middle cerebral artery occlusion (MCAO) model. BDNF production by MSC-BDNF cells was 23-fold greater than that seen in uninfected MSC. Rats that received MSC-BDNF showed significantly more functional recovery than did control rats following MCAO. Specifically, MRI analysis revealed that the rats in the MSC-BDNF group exhibited more significant recovery from ischemia after 7 and 14 days. The number of TUNEL-positive cells in the ischemic boundary zone was significantly smaller in animals treated with MSC-BDNF compared to animals in the control group. These data suggest that MSC transfected with the BDNF gene may be useful in the treatment of cerebral ischemia and may represent a new strategy for the treatment of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Bone Marrow as a Potential Source of Hepatic Oval Cells
Petersen, B. E., Bowen, W. C., Patrene, K. D., Mars, W. M., Sullivan, A. K., Murase, N., Boggs, S. S., Greenberger, J. S., & Goff, J. P. (1999) · Science · doi:10.1126/science.284.5417.1168 · Cited by 2,378
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion
Terada, N., Hamazaki, T., Oka, M., Hoki, M., Mastalerz, D. M., Nakano, Y., Meyer, E. M., Morel, L., Petersen, B. E., & Scott, E. W. (2002) · Nature · doi:10.1038/nature730 · Cited by 1,999
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro
Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T. B., Saporta, S., Janssen, W., Patel, N., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7389 · Cited by 1,562
Changing potency by spontaneous fusion
Ying, Q.-L., Nichols, J., Evans, E. P., & Smith, A. G. (2002) · Nature · doi:10.1038/nature729 · Cited by 1,494 · cited 1×
“Two recent reports [35,36] suggested the possibility that Y-positive cells of bone marrow origin fuse with embryonic stem cells rather than transdifferentiating into cells characteristic of various tissues.”
BackgroundNerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections
Hefti, F. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02155.1986 · Cited by 1,450
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3
Lamballe, F., Klein, R., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90442-2 · Cited by 1,080
Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery
Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., Katakowski, M., Zhang, L. J., Lu, M., Janakiraman, N., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.514 · Cited by 869
Zhao, L.-R., Duan, W.-M., Reyes, M., Keene, C. D., Verfaillie, C. M., & Low, W. C. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7853 · Cited by 823
Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9706-9713.1998 · Cited by 767
Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakal, M., Sakaki, T., Sugano, S., & Saito, I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3816 · Cited by 606
Neurotrophins and brain insults
Lindvall, O., Kokaia, Z., Bengzon, J., Elme´r, E., & Kokaia, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90139-2 · Cited by 557
Chen, J., Li, Y., Wang, L., Lu, M., Zhang, X., & Chopp, M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00557-3 · Cited by 527
Paxinos, G., Watson, C., Pennisi, M., & Topple, A. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90026-3 · Cited by 482
Snyder, E. Y., Yoon, C., Flax, J. D., & Macklis, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11663 · Cited by 434
Treatment of stroke in rat with intracarotid administration of marrow stromal cells
Li, Y., Chen, J., Wang, L., Lu, M., & Chopp, M. (2001) · Neurology · doi:10.1212/wnl.56.12.1666 · Cited by 431
Ischemic rat brain extracts induce human marrow stromal cell growth factor production
Chen, X., Li, Y., Wang, L., Katakowski, M., Zhang, L., Chen, J., Xu, Y., Gautam, S. C., & Chopp, M. (2002) · Neuropathology · doi:10.1046/j.1440-1789.2002.00450.x · Cited by 382
Neumann-Haefelin, T., Kastrup, A., de Crespigny, A., Yenari, M. A., Ringer, T., Sun, G. H., & Moseley, M. E. (2000) · Stroke · doi:10.1161/01.str.31.8.1965 · Cited by 347
Lu, D., Mahmood, A., Wang, L., Li, Y., Lu, M., & Chopp, M. (2001) · Neuroreport · doi:10.1097/00001756-200103050-00025 · Cited by 333
Schäbitz, W.-R., Sommer, C., Zoder, W., Kiessling, M., Schwaninger, M., & Schwab, S. (2000) · Stroke · doi:10.1161/01.str.31.9.2212 · Cited by 325
Environment Influences Functional Outcome of Cerebral Infarction in Rats
Ohlsson, A.-L., & Johansson, B. B. (1995) · Stroke · doi:10.1161/01.str.26.4.644 · Cited by 323
Schäbitz, W.-R., Schwab, S., Spranger, M., & Hacke, W. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199705000-00003 · Cited by 322
Krasnykh, V., Dmitriev, I., Mikheeva, G., Miller, C. R., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1844-1852.1998 · Cited by 314
Åkerud, P., Canals, J. M., Snyder, E. Y., & Arenas, E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08108.2001 · Cited by 305
Hayashi, T., Abe, K., & Itoyama, Y. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199808000-00009 · Cited by 304
A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis
Bakker, A., Van de Loo, F., Joosten, L., Bennink, M., Arntz, O., Dmitriev, I., Kashentsera, E., Curiel, D., & van den Berg, W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301612 · Cited by 213
Sensitivity and reproducibility in adenoviral infectious titer determination
Nyberg-Hoffman, C., Shabram, P., Li, W., Giroux, D., & Aguilar-Cordova, E. (1997) · Nature Medicine · doi:10.1038/nm0797-808 · Cited by 199
Allay, J. A., Dennis, J. E., Haynesworth, S. E., Majumdar, M. K., Clapp, D. W., Shultz, L. D., Caplan, A. I., & Gerson, S. L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.12-1417 · Cited by 160
Conget, P. A., & Minguell, J. J. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00134-x · Cited by 148
Kawano, Y., Kobune, M., Yamaguchi, M., Nakamura, K., Ito, Y., Sasaki, K., Takahashi, S., Nakamura, T., Chiba, H., Sato, T., et al. (2002) · Blood · doi:10.1182/blood-2002-04-1268 · Cited by 137
Self-citationSelective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Kasono, K., Blackwell, J. L., Douglas, J. T., Dmitriev, I. P., Strong, T. V., Reynolds, P. N., Kropf, D. A., Carroll, W. R., Peters, G. E., Bucy, R. P., et al. (1999) · PubMed · Cited by 133
Tsuda, H., Wada, T., Ito, Y., Uchida, H., Dehari, H., Nakamura, K., Sasaki, K., Kobune, M., Yamashita, T., & Hamada, H. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00062-x · Cited by 130
Self-citationYamashita, K., Wießner, C., Lindholm, D., Thoenen, H., & Hossmann, K. (1997) · Metabolic Brain Disease · doi:10.1007/bf02674671 · Cited by 130
Marx, J. C., Allay, J. A., Persons, D. A., Nooner, S. A., Hargrove, P. W., Kelly, P. F., Vanin, E. F., & Horwitz, E. M. (1999) · Human Gene Therapy · doi:10.1089/10430349950018157 · Cited by 114
Kobune, M., Kawano, Y., Ito, Y., Chiba, H., Nakamura, K., Tsuda, H., Sasaki, K., Dehari, H., Uchida, H., Honmou, O., et al. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00177-2 · Cited by 96
Self-citationAndsberg, G., Kokaia, Z., Klein, R. L., Muzyczka, N., Lindvall, O., & Mandel, R. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0456 · Cited by 81
Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer
Dehari, H., Ito, Y., Nakamura, T., Kobune, M., Sasaki, K., Yonekura, N., KOHAMA, G.-I., & Hamada, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700529 · Cited by 65
Self-citationYamauchi, A., Ito, Y., Morikawa, M., Kobune, M., Huang, J., Sasaki, K., Takahashi, K., Nakamura, K., Dehari, H., Niitsu, Y., et al. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.439 · Cited by 64
Self-citationExperimental models and behavioural tests used in the study of Parkinson's disease.
Mokrý, J. (1995) · PubMed · Cited by 57
Effective Gene Transfer to Human Melanomas via Integrin-Targeted Adenoviral Vectors
Nakamura, T., Sato, K., & Hamada, H. (2002) · Human Gene Therapy · doi:10.1089/10430340252837215 · Cited by 46
Self-citationStem Cells for Neurodegenerative Disorders: Where Can We Go From Here?
Belle, J. E. L., & Svendsen, C. N. (2002) · BioDrugs · doi:10.2165/00063030-200216060-00001 · Cited by 43
Tamura, A., Gotoh, O., & Sano, K. (1986) · PubMed · Cited by 20
Cited by
Stem Cell Paracrine Actions and Tissue Regeneration
Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843
Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., & Bang, O. Y. (2010) · Stem Cells · doi:10.1002/stem.430 · Cited by 779
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Jurcau, A., & Simion, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010014 · Cited by 500
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury
Parr, A. M., Tator, C. H., & Keating, A. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705757 · Cited by 447
Metadata
- Authors
- Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., Kato, K., Honmou, O., Houkin, K., Date, I., & Hamada, H.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 9
- Issue
- 2
- Pages
- 189-197
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2101717161
- Cited by
- 339
- References
- 47
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.